Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial.
Arthritis Res Ther
; 17: 213, 2015 Aug 18.
Article
em En
| MEDLINE
| ID: mdl-26283632
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Pirimidinas
/
Pele
/
Esclerodermia Difusa
/
Transcriptoma
Limite:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2015
Tipo de documento:
Article